SCHEMBL5899559

SCHEMBL5899559

O=C(CNS(=O)(=O)Cc1cc(Cl)cc(Cl)c1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.51
KAT6A Q92794 2/20 0.44
MAPT P10636 5/20 0.42
KMT2A Q03164 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MEN1 O00255 3/20 0.42
HPGD P15428 2/20 0.42
ALOX15 P16050 2/20 0.42
MAPK1 P28482 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP3A4 P08684 1/20 0.42
CES1 P23141 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GAA P10253 1/20 0.42
AGTR1 P30556 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899423 0.89 AKR1C3 (0.49) KAT6AKMT2ASMN1; SMN2MEN1HPGD
SCHEMBL5899484 0.87 ALDH1A1 (0.50) MAPTKMT2ASMN1; SMN2MEN1HPGD
SCHEMBL5320468 0.84 MMP1 (0.56) MAPTKMT2ASMN1; SMN2MEN1HPGD
SCHEMBL24590604 0.84 MAPT (0.57) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL754846 0.78 ALDH1A1 (0.52) KAT6AMAPTKMT2ASMN1; SMN2MEN1
SCHEMBL757793 0.76 HPGD (0.52) KAT6AMAPTKMT2ASMN1; SMN2MEN1
SCHEMBL5899461 0.75 ACLY (0.47) ACLYKAT6AMAPTKMT2AMEN1
SCHEMBL5899475 0.73 ALDH1A1 (0.53) MAPTKMT2ASMN1; SMN2MEN1HPGD
SCHEMBL5899482 0.73 L3MBTL1 (0.60) KAT6AMAPTKMT2AMEN1ALDH1A1
SCHEMBL11323836 0.72 HPGD (0.56) KAT6AMAPTKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 ACLY 1905/4885KAT6A 2440/4885MAPT 3655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.